Skip to main content
Top
Published in: Inflammation 5/2014

01-10-2014

CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population

Authors: Satrupa Das, Sitara Roy, Subhash Kaul, Akka Jyothy, Anjana Munshi

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

In the present study, we evaluated the association of 1059G>C polymorphism in C-reactive protein (CRP) gene with the risk of ischemic and hemorrhagic strokes. We did not find a significant association of this polymorphism with stroke. However, 2 % of mutants were observed in hemorrhagic stroke patients with a 0.01 frequency for the C allele. We also estimated the high-sensitivity C-reactive protein (hsCRP) levels in hemorrhagic stroke and compared the levels with our already published data on ischemic stroke. The hsCRP level in hemorrhagic stroke was found to be significantly elevated in comparison with that in controls (p < 0.001). However, there was no difference in the mean value of hsCRP levels between types of stroke. In conclusion, the G>C polymorphism in the promoter region of the CRP gene is not abundant in the population and cannot be connected with different hsCRP levels and stroke prediction. The CRP level is a useful marker in stroke, but cannot help in differentiating between types of stroke.
Literature
1.
go back to reference Ross, R. 1999. Atherosclerosis—An inflammatory disease. New England Journal of Medicine 340: 115–126.PubMedCrossRef Ross, R. 1999. Atherosclerosis—An inflammatory disease. New England Journal of Medicine 340: 115–126.PubMedCrossRef
2.
go back to reference Stoll, G., and M. Bendszus. 2006. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37: 1923–1932.PubMedCrossRef Stoll, G., and M. Bendszus. 2006. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37: 1923–1932.PubMedCrossRef
3.
go back to reference Nadamuni, S. 2002. Researchers identify stroke subtypes in India. Lancet 359: 500. Nadamuni, S. 2002. Researchers identify stroke subtypes in India. Lancet 359: 500.
4.
go back to reference O’Donnell, M.J., D. Xavier, L. Liu, H. Zhang, S.L. Chin, P. Rao-Melacini, S. Rangarajan, S. Islam, P. Pais, and M.J. McQueen. 2010. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case–control study. Lancet 376: 112–123.PubMedCrossRef O’Donnell, M.J., D. Xavier, L. Liu, H. Zhang, S.L. Chin, P. Rao-Melacini, S. Rangarajan, S. Islam, P. Pais, and M.J. McQueen. 2010. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case–control study. Lancet 376: 112–123.PubMedCrossRef
5.
go back to reference Kaul, S., and A. Munshi. 2012. Genetics of ischemic stroke: Indian perspective. Neurology India 60(5): 498–503.PubMedCrossRef Kaul, S., and A. Munshi. 2012. Genetics of ischemic stroke: Indian perspective. Neurology India 60(5): 498–503.PubMedCrossRef
6.
go back to reference Flex, A., E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, et al. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35: 2270–2275.PubMedCrossRef Flex, A., E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, et al. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35: 2270–2275.PubMedCrossRef
7.
go back to reference Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448–454.PubMedCrossRef Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448–454.PubMedCrossRef
8.
go back to reference Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMedCrossRef Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMedCrossRef
9.
go back to reference Calabro, P., J.T. Willerson, and E.T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930–1932.PubMedCrossRef Calabro, P., J.T. Willerson, and E.T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930–1932.PubMedCrossRef
10.
go back to reference Volanakis, J.E. 2001. Human C-reactive protein: Expression, structure, and function. Molecular Immunology 38: 189–197.PubMedCrossRef Volanakis, J.E. 2001. Human C-reactive protein: Expression, structure, and function. Molecular Immunology 38: 189–197.PubMedCrossRef
11.
go back to reference Meier-Ewert, H.K., P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, and J.M. Mullington. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clinical Chemistry 47: 426–430.PubMed Meier-Ewert, H.K., P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, and J.M. Mullington. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clinical Chemistry 47: 426–430.PubMed
12.
go back to reference Bassuk, S.S., N. Rifai, and P.M. Ridker. 2004. High-sensitivity C-reactive protein: Clinical importance. Current Problems in Cardiology 29: 439–493.PubMed Bassuk, S.S., N. Rifai, and P.M. Ridker. 2004. High-sensitivity C-reactive protein: Clinical importance. Current Problems in Cardiology 29: 439–493.PubMed
13.
go back to reference Pai, J.K., K.J. Mukamal, K.M. Rexrode, and E.B. Rimm. 2008. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 3: e1395.PubMedCrossRefPubMedCentral Pai, J.K., K.J. Mukamal, K.M. Rexrode, and E.B. Rimm. 2008. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 3: e1395.PubMedCrossRefPubMedCentral
14.
go back to reference Brull, D.J., N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D. Lowe, M.J. World, S.E. Humphries, and A.D. Hingorani. 2003. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063–2069.PubMedCrossRef Brull, D.J., N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D. Lowe, M.J. World, S.E. Humphries, and A.D. Hingorani. 2003. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063–2069.PubMedCrossRef
15.
go back to reference Claes, L., J. Katarina, B. Christian, N. Staffan, J. Christina, and L. Per. 2006. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37: 2018–2023.CrossRef Claes, L., J. Katarina, B. Christian, N. Staffan, J. Christina, and L. Per. 2006. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37: 2018–2023.CrossRef
16.
go back to reference Qi, W., D. Hu, T. Jia-rong, Z. Lan, X. Yu-jun, Y. Jiang-tao, W. Wei, H. Ru-tai, W. Cong-yi, and W. Dao-wen. 2009. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacologica Sinica 30(3): 291–298.CrossRef Qi, W., D. Hu, T. Jia-rong, Z. Lan, X. Yu-jun, Y. Jiang-tao, W. Wei, H. Ru-tai, W. Cong-yi, and W. Dao-wen. 2009. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacologica Sinica 30(3): 291–298.CrossRef
17.
go back to reference Munshi, A., S. Shehnaz, S. Kaul, B. Pulla Reddy, S. Alladi, and A. Jyothy. 2008. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of Neurological Sciences 272: 132–135.CrossRef Munshi, A., S. Shehnaz, S. Kaul, B. Pulla Reddy, S. Alladi, and A. Jyothy. 2008. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of Neurological Sciences 272: 132–135.CrossRef
18.
go back to reference Rajeshwar, K., S. Kaul, A. Al-Hazzani, M.S. Babu, N. Balakrishna, V. Sharma, et al. 2012. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Inflammation 35(3): 978–984.PubMedCrossRef Rajeshwar, K., S. Kaul, A. Al-Hazzani, M.S. Babu, N. Balakrishna, V. Sharma, et al. 2012. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Inflammation 35(3): 978–984.PubMedCrossRef
19.
go back to reference Bonow, R.O., L.A. Smaha, S.C. Smith Jr., G.A. Mensah, and C. Lenfant. 2002. World Heart Day 2002: The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 106: 1602–1605.PubMedCrossRef Bonow, R.O., L.A. Smaha, S.C. Smith Jr., G.A. Mensah, and C. Lenfant. 2002. World Heart Day 2002: The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 106: 1602–1605.PubMedCrossRef
20.
go back to reference Feigin, V.L. 2005. Stroke epidemiology in the measurements developing world. Lancet 365: 2160–2161.PubMedCrossRef Feigin, V.L. 2005. Stroke epidemiology in the measurements developing world. Lancet 365: 2160–2161.PubMedCrossRef
21.
go back to reference Ridker, P.M., E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto, and J.J. Kastelein. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 359: 2195–2207.PubMedCrossRef Ridker, P.M., E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto, and J.J. Kastelein. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 359: 2195–2207.PubMedCrossRef
22.
go back to reference Feigin, V.L., C.M. Lawes, D.A. Bennett, and C.S. Anderson. 2003. Stroke epidemiology: A review of population-based studies of incidence, prevalence and case-fatality in the late 20th century. Lancet Neurology 2(1): 43–53.CrossRef Feigin, V.L., C.M. Lawes, D.A. Bennett, and C.S. Anderson. 2003. Stroke epidemiology: A review of population-based studies of incidence, prevalence and case-fatality in the late 20th century. Lancet Neurology 2(1): 43–53.CrossRef
23.
go back to reference Castillo, J., and I. Rodriguez. 2004. Biochemical changes and inflammatory response as markers for brain ischaemia: Molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovascular Diseases 17(suppl 1): 7–18.PubMedCrossRef Castillo, J., and I. Rodriguez. 2004. Biochemical changes and inflammatory response as markers for brain ischaemia: Molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovascular Diseases 17(suppl 1): 7–18.PubMedCrossRef
24.
go back to reference Morita, A., T. Nakayama, and M. Soma. 2006. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. American Journal of Hypertension 19: 593–600.PubMedCrossRef Morita, A., T. Nakayama, and M. Soma. 2006. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. American Journal of Hypertension 19: 593–600.PubMedCrossRef
25.
go back to reference Roudbary, S.A., F. Saadat, K. Forghanparast, and R. Sohrabnejad. 2011. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Medica Iranica 49(3): 149–152.PubMed Roudbary, S.A., F. Saadat, K. Forghanparast, and R. Sohrabnejad. 2011. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Medica Iranica 49(3): 149–152.PubMed
26.
go back to reference Rajput, M.R., M.A. Lakhair, M.A. Shaikh, M.S. Rind, and Bano R. Zafarullah. 2011. C-reactive protein (CRP) and other risk factors in acute ischemic stroke patients. Journal of Liaquat University of Medical and Health Sciences (JLUMHS) 10(3): 131–133. Rajput, M.R., M.A. Lakhair, M.A. Shaikh, M.S. Rind, and Bano R. Zafarullah. 2011. C-reactive protein (CRP) and other risk factors in acute ischemic stroke patients. Journal of Liaquat University of Medical and Health Sciences (JLUMHS) 10(3): 131–133.
27.
go back to reference Napoli, M.D., F. Papa, and V. Bocola. 2001. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 32(4): 917–924.PubMedCrossRef Napoli, M.D., F. Papa, and V. Bocola. 2001. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 32(4): 917–924.PubMedCrossRef
28.
go back to reference Muir, K.W., C.J. Weir, W. Alwan, I.B. Squire, and K.R. Lees. 1999. C-reactive protein and outcome after ischemic stroke. Stroke 30(5): 981–985.PubMedCrossRef Muir, K.W., C.J. Weir, W. Alwan, I.B. Squire, and K.R. Lees. 1999. C-reactive protein and outcome after ischemic stroke. Stroke 30(5): 981–985.PubMedCrossRef
29.
go back to reference Chaudhuri, J.R., R.M. Kandadai, U. Matapathi, S. Alluri, B. Banda, and V.C.S. Bandaru. 2013. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iranian Journal of Neurology 12(3): 92–97.PubMedPubMedCentral Chaudhuri, J.R., R.M. Kandadai, U. Matapathi, S. Alluri, B. Banda, and V.C.S. Bandaru. 2013. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iranian Journal of Neurology 12(3): 92–97.PubMedPubMedCentral
30.
go back to reference Den Hertog, H.M., J.A. Van Rossum, H.B. Van der Worp, H.M. Van Gemert, R. De Jonge, P.J. Koudstaal, et al. 2009. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. Journal of Neurology 256(12): 2003–2008.CrossRef Den Hertog, H.M., J.A. Van Rossum, H.B. Van der Worp, H.M. Van Gemert, R. De Jonge, P.J. Koudstaal, et al. 2009. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. Journal of Neurology 256(12): 2003–2008.CrossRef
31.
go back to reference Carlson, Christopher S., Shelley Force Aldred, Philip K. Lee, Russell P. Tracy, Stephen M. Schwartz, Mark Rieder, O. Kiang Liu, Dale Williams, E. Carlos Iribarren, Cora Lewis, Myriam Fornage, Eric Boerwinkle, Myron Gross, Cashell Jaquish, A. Nickerson Deborah, Richard M. Myers, David S. Siscovick, and Alexander P. Reiner. 2005. Polymorphisms within the C-reactiveprotein (CRP) promoter region are associated with plasma CRP levels. American Journal of Human Genetics 77: 64–77.PubMedCrossRefPubMedCentral Carlson, Christopher S., Shelley Force Aldred, Philip K. Lee, Russell P. Tracy, Stephen M. Schwartz, Mark Rieder, O. Kiang Liu, Dale Williams, E. Carlos Iribarren, Cora Lewis, Myriam Fornage, Eric Boerwinkle, Myron Gross, Cashell Jaquish, A. Nickerson Deborah, Richard M. Myers, David S. Siscovick, and Alexander P. Reiner. 2005. Polymorphisms within the C-reactiveprotein (CRP) promoter region are associated with plasma CRP levels. American Journal of Human Genetics 77: 64–77.PubMedCrossRefPubMedCentral
32.
go back to reference Zee, R.Y.L., and P.M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162: 217–219.PubMedCrossRef Zee, R.Y.L., and P.M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162: 217–219.PubMedCrossRef
33.
go back to reference Zacho, J., A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine 359(18): 1897–1908.PubMedCrossRef Zacho, J., A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine 359(18): 1897–1908.PubMedCrossRef
34.
go back to reference Napoli, M.D., M.S.V. Elkind, D.A. Godoy, P. Singh, F. Papa, and A. Popa-Wagner. 2011. Role of C-reactive protein in cerebrovascular disease. Expert Review of Cardiovascular Therapy 9(12): 1565–1584.PubMedCrossRef Napoli, M.D., M.S.V. Elkind, D.A. Godoy, P. Singh, F. Papa, and A. Popa-Wagner. 2011. Role of C-reactive protein in cerebrovascular disease. Expert Review of Cardiovascular Therapy 9(12): 1565–1584.PubMedCrossRef
Metadata
Title
CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population
Authors
Satrupa Das
Sitara Roy
Subhash Kaul
Akka Jyothy
Anjana Munshi
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9897-y

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.